[ in·sid·er trade ]
 
Insider is a term describing a director or senior officer of a publicly traded company, as well as any person or entity, that beneficially owns more than 10% of a company's voting shares. Insiders have to comply with strict disclosure requirements with regard to the sale or purchase of the shares of their company. 

Company insider at a ophthalmic Biotech company buys 35,000 shares of their company increasing their holdings to 4,254,748.

Stuart Grant increased his position of Eyenovia, Inc (EYEN) by 35,000 share this month.


COMPANY INFORMATION
  EYEN by TradingView   
 
 
Company Info:
Eyenovia is a clinical stage ophthalmic company developing a pipeline of advanced therapeutics based on its proprietary microdose array print (MAP™) platform technology.

Eyenovia aims to achieve clinical microdosing of next-generation formulations of well-established ophthalmic pharmaceutical agents using its high-precision targeted ocular delivery system, which has the potential to replace conventional eyedropper delivery and improve safety, tolerability, patient compliance and topical delivery success for ophthalmic eye treatments.

LATEST INSIDER ACTIVITY
INSIDER: 
Stuart Grant
 
SHARES BOUGHT: 
35,000
 
PURCHASE DATE: 
03/05/2021
TITLE: 
10% Ownership
 
% INCREASE: 
1%
 
FILE DATE: 
03/08/2021 
INSIDER PURCHASE PRICE
$5.50
 
Insider Notes: 
N/A
 
 
ANALYST RECOMMENDATION
 
 
TARGET PRICE:  
$12
 
TARGET GAIN: 
90%
 
 
AVERAGE RATING: 
BUY
 
ANALYST COVERING: 
4
IMPORTANT DISCLOSURE 
 
Insidercalls.com is an EDUCATIONAL WEBSITE and INFORMATION AGGREGATOR. We are NOT FINANCIAL ADVISORS or licensed that provide any financial advice. Before making any investment, you should consult a financial advisor and verify that all information on this website is accurate so you can make your best decision. Stocks go up and down in any given day, so ACT RESPONSIBLE for your own decisions and act wisely to your specific financial situation.
 
  
TECHNICAL ANALYSIS
 
 
 
 
 
 
 
 
  
 
 

Related Articles